|
AEVIS VICTORIA SA / Key word(s): Acquisition Ad hoc announcement pursuant to Art. 53 LR Fribourg, 8 October 2024 AEVIS VICTORIA SA (AEVS.SW) – Swiss Medical Network strengthens its presence in Ticino with the acquisition of «Centromedico» Swiss Medical Network, the operating subsidiary of AEVIS VICTORIA SA dedicated to healthcare, is acquiring PDS Medical SA, which operates 10 group practices in the Canton of Ticino under the brand name «Centromedico» and thus provides a significant proportion of primary medical care for the population of Ticino. PDS Medical SA recorded revenues of approximately CHF 42 million in 2023. The parties have agreed not to disclose the purchase price. With this acquisition, Swiss Medical Network strengthens its position in the canton of Ticino and lays the foundation for a second integrated care region in Switzerland under the name «Rete Sant'Anna». Based on the model of the Réseau de l'Arc in the Bernese Jura, where Switzerland's first fully integrated care organization has been operating since 1 January 2024, the VIVA health plan will also be available in Ticino from 1 January 2025. This concept focuses on preventive and comprehensive healthcare for members, as well as close cooperation between outpatient, inpatient and home care services. For further information: AEVIS VICTORIA SA - Investing for a better life End of Inside Information |
2004513 08-Oct-2024 CET/CEST
P R O D U C T S U G G E S T I O N S
The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.
The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.
If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.
For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.
1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.
Special
